175 related articles for article (PubMed ID: 3331321)
61. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
[TBL] [Abstract][Full Text] [Related]
62. In vitro/in vivo functionality of Catapres-TTS.
Enscore DJ; Osborne JL; Shaw JE
Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
[TBL] [Abstract][Full Text] [Related]
63. Relative bioavailability of four controlled-release nifedipine products.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
[TBL] [Abstract][Full Text] [Related]
64. [Comparison of the antihypertensive action of normal clonidine and delayed-preparation clonidine].
Ambrosioni E; Caldari R; Costa FV; Magnani B
G Clin Med; 1979 Jul; 60(7):569-82. PubMed ID: 548293
[No Abstract] [Full Text] [Related]
65. Safe use of clonidine, nifedipine and vitamin K in hepatic porphyria.
Bhadoria DP; Srivastava AK; Sharma M; Deswal A; Bhadoria P; Malhotra KK
J Assoc Physicians India; 1988 Nov; 36(11):675-6. PubMed ID: 3248999
[No Abstract] [Full Text] [Related]
66. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
[TBL] [Abstract][Full Text] [Related]
67. [The relation of hypotensive effects of nifedipine and clonidine and changes in platelet-free calcium and serum-free calcium in essential hypertension].
Chen S; Zhao GS; Guo JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Oct; 16(5):258-60, 316. PubMed ID: 3234212
[No Abstract] [Full Text] [Related]
68. Catapres-TTS: a two year posttrial followup.
Kellaway GS; Lubbe WF
N Z Med J; 1988 Jun; 101(847 Pt 1):380. PubMed ID: 2970607
[No Abstract] [Full Text] [Related]
69. GITS--one more dosage form of nifedipine.
Turakhia DP
J Assoc Physicians India; 1990 Jun; 38(6):453-4. PubMed ID: 2384476
[No Abstract] [Full Text] [Related]
70. [Pharmacodynamic interaction of clonidine and nifedipine].
Moiseev VS; Ivleva AIa; Krasnobaeva GM; Akopian LM; Kobaleva ZhD
Kardiologiia; 1987 Feb; 27(2):77-80. PubMed ID: 3573528
[No Abstract] [Full Text] [Related]
71. Clinical pharmacokinetics of nifedipine. Implications for the care of the elderly.
Elliott HL; Meredith PA
Drugs Aging; 1997 Dec; 11(6):470-9. PubMed ID: 9413704
[TBL] [Abstract][Full Text] [Related]
72. Transdermal clonidine application: long-term results in essential hypertension.
Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
[TBL] [Abstract][Full Text] [Related]
73. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
Save T; Shah MU; Ghamande AR; Venkitachalam P
J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
[TBL] [Abstract][Full Text] [Related]
74. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
Chen SW; Vidt DG
Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
[TBL] [Abstract][Full Text] [Related]
75. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients.
Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908
[TBL] [Abstract][Full Text] [Related]
76. Nifedipine gastrointestinal therapeutic system: an overview of its antiatherosclerotic effects.
Ueng KC; Lin MC; Chan KC; Lin CS
Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):769-80. PubMed ID: 17916061
[TBL] [Abstract][Full Text] [Related]
77. Your patient and angina.
Matney J
RDH; 1991 May; 11(5):26, 27, 30. PubMed ID: 1909448
[No Abstract] [Full Text] [Related]
78. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
[TBL] [Abstract][Full Text] [Related]
79. The use of sublingual nifedipine in a patient with a clonidine overdose.
Dire DJ; Kuhns DW
J Emerg Med; 1988; 6(2):125-8. PubMed ID: 3290324
[TBL] [Abstract][Full Text] [Related]
80. Therapeutic Differences in 24-h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery Technologies.
Pollak PT; Herman RJ; Feldman RD
Clin Transl Sci; 2017 May; 10(3):217-224. PubMed ID: 28233944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
